Also trades as: WINTW (OTC) · $vol 0M
WINT OTC
Windtree Therapeutics, Inc.
1W: +0.0%
1M: +0.0%
3M: -98.2%
YTD: -99.0%
1Y: -99.6%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±43.4%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$84K
-2.4% ▼
Operating Income
-$25M
-42.6% ▼
Net Income
-$5M
+73.0% ▲
EPS (Diluted)
$-104.35
+97.8% ▲
EBITDA
-$1M
+92.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $638K | $869K | $1M | $82K | $84K |
| Gross Profit | -$638K | -$869K | -$1M | -$82K | -$84K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $15M | $18M | $11M | $8M | $16M |
| SG&A Expenses | $15M | $14M | $11M | $9M | $9M |
| Operating Expenses | $30M | $31M | $20M | $17M | $25M |
| Operating Income | -$30M | -$77M | -$41M | -$18M | -$25M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $125K | $114K | $53K | $50K | $235K |
| Income Before Tax | -$33M | -$78M | -$41M | -$20M | -$2M |
| Tax Expense | -$2M | -$10M | -$1M | $0 | $4M |
| Net Income | -$30M | -$68M | -$39M | -$20M | -$5M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-93616.00 | $-122924.00 | $-56011.00 | $-4711.54 | $-104.35 |
| EBITDA | -$32M | -$77M | -$39M | -$20M | -$1M |
| Shares Outstanding | 348 | 550 | 700 | 4306 | 52583 |